Clinical outcomes of chemoradiotherapy for locally recurrent rectal cancer

Radiation Oncology

Volumn 6, Issue 1, 2011, Pages

  Lee, Joo Ho ^a,b   Kim, Dae Yong ^a   Kim, Sun Young ^a   Park, Ji Won ^a   Choi, Hyo Seong ^a   Oh, Jae Hwan ^a   Chang, Hee Jin ^a   Kim, Tae Hyun ^a   Park, Suk Won ^c  

^a National Cancer Center   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Chung Ang University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROPYRIMIDINE DERIVATIVE; IRINOTECAN; OXALIPLATIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; FEMALE; HUMAN; LOCOREGIONAL RELAPSE FREE SURVIVAL; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROGNOSIS; RADIATION DOSE; RECTUM CANCER; RELAPSE FREE SURVIVAL; RETROSPECTIVE STUDY; SURVIVAL; SYMPTOM; TREATMENT OUTCOME; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; DISEASE FREE SURVIVAL; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; RADIATION RESPONSE; RECTUM TUMOR; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; TREATMENT OUTCOME;

EID: 79956190659     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-6-51     Document Type: Article

References (24)

1. Colorectal Cancer Collaborative Group Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomised trials. Lancet 2001, 358:1291-1304. Colorectal Cancer Collaborative Group.
2. Heald RJ, Moran BJ, Ryall RD, Sexton R, MacFarlane JK. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg 1998, 133:894-899. 10.1001/archsurg.133.8.894, 9711965.
3. Bakx R, Visser O, Josso J, Meijer S, Slors JF, van Lanschot JJ. Management of recurrent rectal cancer: a population based study in greater Amsterdam. World J Gastroenterol 2008, 14:6018-6023. 10.3748/wjg.14.6018, 2760194, 18932280.
4. Palmer G, Martling A, Cedermark B, Holm T. A population-based study on the management and outcome in patients with locally recurrent rectal cancer. Ann Surg Oncol 2007, 14:447-454. 10.1245/s10434-006-9256-9, 17139457.
5. Kim TH, Chang HJ, Kim DY, Jung KH, Hong YS, Kim SY, Park JW, Oh JH, Lim SB, Choi HS, Jeong SY. Pathologic nodal classification is the most discriminating prognostic factor for disease-free survival in rectal cancer patients treated with preoperative chemoradiotherapy and curative resection. Int J Radiat Oncol Biol Phys 2010, 77:1158-1165. 10.1016/j.ijrobp.2009.06.019, 19800178.
6. Dresen RC, Gosens MJ, Martijn H, Nieuwenhuijzen GA, Creemers GJ, Daniels-Gooszen AW, van den Brule AJ, van den Berg HA, Rutten HJ. Radical resection after IORT-containing multimodality treatment is the most important determinant for outcome in patients treated for locally recurrent rectal cancer. Ann Surg Oncol 2008, 15:1937-1947. 10.1245/s10434-008-9896-z, 2467498, 18389321.
7. Hahnloser D, Nelson H, Gunderson LL, Hassan I, Haddock MG, O'Connell MJ, Cha S, Sargent DJ, Horgan A. Curative potential of multimodality therapy for locally recurrent rectal cancer. Ann Surg 2003, 237:502-508. 1514480, 12677146.
8. Heriot AG, Byrne CM, Lee P, Dobbs B, Tilney H, Solomon MJ, Mackay J, Frizelle F. Extended radical resection: the choice for locally recurrent rectal cancer. Dis Colon Rectum 2008, 51:284-291. 10.1007/s10350-007-9152-9, 18204879.
9. Kusters M, Dresen RC, Martijn H, Nieuwenhuijzen GA, van de Velde CJ, van den Berg HA, Beets-Tan RG, Rutten HJ. Radicality of resection and survival after multimodality treatment is influenced by subsite of locally recurrent rectal cancer. Int J Radiat Oncol Biol Phys 2009, 75:1444-1449. 10.1016/j.ijrobp.2009.01.015, 19395199.
10. Bouchard P, Efron J. Management of recurrent rectal cancer. Ann Surg Oncol 2010, 17:1343-1356. 10.1245/s10434-009-0861-2, 20041351.
11. Watson AJ, Lolohea S, Robertson GM, Frizelle FA. The role of positron emission tomography in the management of recurrent colorectal cancer: a review. Dis Colon Rectum 2007, 50:102-114. 10.1007/s10350-006-0735-7, 17115340.
12. Kim TH, Kim DY, Jung KH, Hong YS, Kim SY, Park JW, Lim SB, Choi HS, Jeong SY, Oh JH. The role of omental flap transposition in patients with locoregional recurrent rectal cancer treated with reirradiation. J Surg Oncol 2010, 102:789-95. 10.1002/jso.21737, 20886555.
13. Pacelli F, Tortorelli AP, Rosa F, Bossola M, Sanchez AM, Papa V, Valentini V, Doglietto GB. Locally recurrent rectal cancer: prognostic factors and long-term outcomes of multimodal therapy. Ann Surg Oncol 2010, 17:152-162. 10.1245/s10434-009-0737-5, 19834766.
14. Wiig JN, Larsen SG, Giercksky KE. Operative treatment of locally recurrent rectal cancer. Recent Results Cancer Res 2005, 165:136-147. 10.1007/3-540-27449-9_15, 15865028.
15. Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M, . Study Group for Therapies of Rectal Malignancies (STORM) Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Int J Radiat Oncol Biol Phys 2006, 64:1129-1139. 10.1016/j.ijrobp.2005.09.017, 16414206, Study Group for Therapies of Rectal Malignancies (STORM).
16. Larsen SG, Wiig JN, Giercksky KE. Hydronephrosis as a prognostic factor in pelvic recurrence from rectal and colon carcinomas. Am J Surg 2005, 190:55-60. 10.1016/j.amjsurg.2004.07.043, 15972173.
17. Park JK, Kim YW, Hur H, Kim NK, Min BS, Sohn SK, Choi YD, Kim YT, Ahn JB, Roh JK, Keum KC, Seong JS. Prognostic factors affecting oncologic outcomes in patients with locally recurrent rectal cancer: impact of patterns of pelvic recurrence on curative resection. Langenbecks Arch Surg 2009, 394:71-77. 10.1007/s00423-008-0391-6, 18663464.
18. Wiig JN, Tveit KM, Poulsen JP, Olsen DR, Giercksky KE. Preoperative irradiation and surgery for recurrent rectal cancer. Will intraoperative radiotherapy (IORT) be of additional benefit? A prospective study. Radiother Oncol 2002, 62:207-213. 10.1016/S0167-8140(01)00486-8, 11937248.
19. Saito N, Koda K, Takiguchi N, Oda K, Ono M, Sugito M, Kawashima K, Ito M. Curative surgery for local pelvic recurrence of rectal cancer. Dig Surg 2003, 20:192-199. 10.1159/000070385, 12759498.
20. Mohiuddin M, Marks G, Marks J. Long-term results of reirradiation for patients with recurrent rectal carcinoma. Cancer 2002, 95:1144-1150. 10.1002/cncr.10799, 12209702.
21. Schurr P, Lentz E, Block S, Kaifi J, Kleinhans H, Cataldegirmen G, Kutup A, Schneider C, Strate T, Yekebas E, Izbicki J. Radical redo surgery for local rectal cancer recurrence improves overall survival: a single center experience. J Gastrointest Surg 2008, 12:1232-1238. 10.1007/s11605-008-0517-8, 18446418.
22. Asoglu O, Karanlik H, Muslumanoglu M, Igci A, Emek E, Ozmen V, Kecer M, Parlak M, Kapran Y. Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: a single institute experience. Eur J Surg Oncol 2007, 33:1199-1206.
23. Bedrosian I, Giacco G, Pederson L, Rodriguez-Bigas MA, Feig B, Hunt KK, Ellis L, Curley SA, Vauthey JN, Delclos M, Crane CH, Janjan N, Skibber JM. Outcome after curative resection for locally recurrent rectal cancer. Dis Colon Rectum 2006, 49:175-182. 10.1007/s10350-005-0276-5, 16392024.
24. Suzuki K, Gunderson LL, Devine RM, Weaver AL, Dozois RR, Ilstrup DM, Martenson JA, O'Connell MJ. Intraoperative irradiation after palliative surgery for locally recurrent rectal cancer. Cancer 1995, 75:939-952. 10.1002/1097-0142(19950215)75:4<939::AID-CNCR2820750408>3.0.CO;2-E, 7531113.